Construction of a value assessment framework for antineoplastic agents based on multi-criteria decision analysis in the context of diagnosis related group
Pharmacoeconomics and Policy · 2025
DOI: 10.1016/j.pharp.2025.03.002 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoeconomics and Policy, 2025. Verfasst von Na Li und 7 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, National Health Commission of the People's Republic of China.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Förderung
- National Natural Science Foundation of China
- National Health Commission of the People's Republic of China
Zitieren
APA
Li, N., Fu, W., Lei, J., Zhang, J., You, C., Lin, J., Zheng, B., & Liu, M. (2025). Construction of a value assessment framework for antineoplastic agents based on multi-criteria decision analysis in the context of diagnosis related group. Pharmacoeconomics and Policy. https://doi.org/10.1016/j.pharp.2025.03.002
Vancouver
Li N, Fu W, Lei J, Zhang J, You C, Lin J, et al. Construction of a value assessment framework for antineoplastic agents based on multi-criteria decision analysis in the context of diagnosis related group. Pharmacoeconomics and Policy. 2025. doi:10.1016/j.pharp.2025.03.002
BibTeX
@article{Li2025,
author = {Li, Na and Fu, Wu and Lei, Jianying and Zhang, Jiahao and You, Caicong and Lin, Jingwen and Zheng, Bin and Liu, Maobai},
title = {Construction of a value assessment framework for antineoplastic agents based on multi-criteria decision analysis in the context of diagnosis related group},
journal = {Pharmacoeconomics and Policy},
year = {2025},
doi = {10.1016/j.pharp.2025.03.002}
}
EUVIMED